UI Health Care receives Specialized Program of Research Excellence funding for neuroendocrine tumors.

Using zebrafish, UI professor Colin Kenny studies uveal melanoma to better understand how it forms and spreads — and how it can be treated. His dedication to research comes from what he calls the “sheer thrill of discovery.”

James Byrne named a finalist for the 2026 BioInnovation Institute & Science Prize for Innovation

Colin Kenny, PhD, has been recognized with multiple awards, but he’s quick to shift the focus to his students. At a recent conference, members of his lab presented research examining how melanoma develops and spreads — work that not only advances the field but also earned awards for each presenter.

Lead study author Ksenia Krupina will join UI Health Care in 2026 to continue her research.

Garry Buettner, a scientist who spent decades researching the cancer-fighting potential of intravenous vitamin C, became a patient himself, and benefited from the very treatment he helped pioneer—demonstrating both the personal and scientific impact of his work.

Katie Colling was named winner of the 2025 3MT competition.

These opinions from Mark Burkard, MD, PhD, Mary Charlton, PhD, and Bradley Hiatt, DO, were originally published Nov. 22, 2025, in the Des Moines Register.